Arcutis Announces New Long-Term Data Of Roflumilast Cream 0.15% For The Treatment Of Mild To Moderate Atopic Dermatitis (AD) In Adults And Children Down To Age Six Presented At Revolutionizing Alopecia Areata, Vitiligo, And Eczema Conference

Media coverage

• Title	Arcutis Announces New Long-Term Data Of Roflumilast Cream 0.15% For The Treatment Of Mild To Moderate Atopic Dermatitis (AD) In Adults And Children Down To Age Six Presented At Revolutionizing Alopecia Areata, Vitiligo, And Eczema Conference
  Media name/outlet	MENAFN -Press Releases (English)
  Country/Territory	Jordan
  Date	10/06/24
  Persons	Emma Guttman